Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

Cited by (1,000)

Items 501–600 of 1,000

1. Unfolded Protein Response and Macroautophagy in Alzheimer’s, Parkinson’s and Prion Diseases
   Irina Milisav, Dušan Šuput, Samo Ribarič · 2015 · Molecules
2. Knockin’ on heaven’s door: Molecular mechanisms of neuronal tau uptake
   Samantha De La‐Rocque, Edoardo Moretto, Ioana Butnaru, Giampietro Schiavo · 2020 · Journal of Neurochemistry
3. Prion, Amyloid β-derived Cu(II) Ions, or Free Zn(II) Ions Support S-Nitroso-dependent Autocleavage of Glypican-1 Heparan Sulfate
   Katrin Mani, Fang Cheng, Birgitta Havsmark, Mats Jönsson, Mattias Belting, Lars‐Âke Fransson · 2003 · Journal of Biological Chemistry
4. Modulation of Amyloid β Peptide1-42 Cytotoxicity and Aggregation in Vitro by Glucose and Chondroitin Sulfate
   Xavier Fernàndez‐Busquets, Jovita Ponce, R. Bravo, Muriel Arimon, Tània Martiáñez, Alejandro Gella, Josep Cladera, N. Durany · 2010 · Current Alzheimer Research
5. A sulfated proteoglycan aggregation factor mediates amyloid-β peptide fibril formation and neurotoxicity
   JoAnne McLaurin, Trudy Franklin, William J. Kuhns, Paul E. Fraser · 1999 · Amyloid
6. Biomolecular condensation of the microtubule-associated protein tau
   Tina Ukmar, Susanne Wegmann, Markus Zweckstetter · 2019 · Seminars in Cell and Developmental Biology
7. Molecular Pathology of Alzheimer’s Disease and Related Disorders
   Stephen D. Ginsberg, Marie Luise Schmidt, Peter B. Crino, James H. Eberwine, Virginia M.‐Y. Lee, John Q. Trojanowski · 1999 · Cerebral cortex
8. Low molecular weight glycosaminoglycan blockade of β-amyloid induced neuropathology
   Mark Walzer, Stanley A. Lorens, Matthew J. Hejna, Jawed Fareed, Israel Hanin, Umberto Cornelli, John Michael Lee · 2002 · European Journal of Pharmacology
9. Molecular rules governing the structural polymorphism of amyloid fibrils in neurodegenerative diseases
   Dan Li, Cong Liu · 2023 · Structure
10. How Does Hyperphopsphorylation Promote Tau Aggregation and Modulate Filament Structure and Stability?
    Liang Xu, Jie Zheng, Martin Margittai, Ruth Nussinov, Buyong Ma · 2016 · ACS Chemical Neuroscience
11. Red Ginseng Inhibits Tau Aggregation and Promotes Tau Dissociation In Vitro
    Soo Jung Shin, Yong Ho Park, Seong Gak Jeon, Sujin Kim, Yunkwon Nam, Sang‐Muk Oh, Yong Yook Lee, Minho Moon · 2020 · Oxidative Medicine and Cellular Longevity
12. Conformational fingerprinting of tau variants and strains by Raman spectroscopy
    George Devitt, Anna Crisford, William Rice, Hilary A. Weismiller, Zhanyun Fan, Caitlin Commins, Bradley T. Hyman, Martin Margittai, Sumeet Mahajan, Amritpal K. Mudher · 2021 · RSC Advances
13. A brief history of tau: the evolving view of the microtubule-associated protein tau in neurodegenerative diseases
    G. Lace, Stephen B. Wharton, Paul G. Ince · 2007 · Clinical Neuropathology
14. The novel Tau mutation G335S: clinical, neuropathological and molecular characterization
    Salvatore Spina, Jill R. Murrell, Hirotaka Yoshida, Bernardino Francesco Ghetti, Niamh Bermingham, Brian J. Sweeney, Stephen R. Dlouhy, R. Anthony Crowther, Michel Goedert, Catherine Keohane · 2006 · Acta Neuropathologica
15. The Tauopathies
    Michel Goedert, Masato Hasegawa · 1999 · American Journal Of Pathology
16. N368-Tau fragments generated by legumain are detected only in trace amount in the insoluble Tau aggregates isolated from AD brain
    Schlegel, Kerstin, Awwad, Khader, Heym, Roland G., Holzinger, David, Doell, Annika, Barghorn, Stefan, Jahn, Thomas R., Klein, Corinna, Mordashova, Yulia, Schulz, Michael et al. · 2019 · Acta Neuropathologica Communications
17. Cryo-EM structures of pathogenic fibrils and their impact on neurodegenerative disease research
    Tiffany W. Todd, Naeyma N. Islam, Casey N. Cook, Thomas R. Caulfield, Leonard Petrucelli · 2024 · Neuron
18. A functional fragment of Tau forms fibers without the need for an intermolecular cysteine bridge
    Isabelle Huvent, Amina Kamah, François‐Xavier Cantrelle, Nicolas Barois, Christian Slomianny, Caroline Smet‐Nocca, Isabelle Landrieu, Guy M. Lippens · 2014 · Biochemical and Biophysical Research Communications
19. Modulation of amyloid assembly by glycosaminoglycans: from mechanism to biological significance
    Noé Quittot, Mathew Sebastiao, Steve Bourgault · 2017 · Biochemistry and Cell Biology
20. Sulfated glycosaminoglycans in protein aggregation diseases
    Kazuchika Nishitsuji, Kenji Uchimura · 2017 · Glycoconjugate Journal
21. Production of recombinant tau oligomers in vitro
    Benjamin Combs, Chelsea T. Tiernan, Chelsey Hamel, Nicholas M. Kanaan · 2017 · Methods in cell biology
22. Nanopolyphenol rejuvenates microglial surveillance of multiple misfolded proteins through metabolic reprogramming
    Dayuan Wang, Xiao Qin Gu, Xinyi Ma, Jun Chen, Qizhi Zhang, Zhihua Yu, Juan Li, Hu Meng, Xiaofang Tan, Yuyun Tang et al. · 2022 · Acta Pharmaceutica Sinica B
23. pH Induced Structural Modulation and Interfacial Activity of Hemoglobin at the Air/Water Interface
    Mrityunjoy Mahato, Prabir Kumar Pal, Tapanendu Kamilya, Ratan Sarkar, G. B. Talapatra · 2009 · The Journal of Physical Chemistry B
24. Molecular insights into the reversible formation of tau protein fibrils
    Yin Luo, Paul D. Dinkel, Xiang Yu, Martin Margittai, Jie Zheng, Ruth Nussinov, Guanghong Wei, Buyong Ma · 2013 · Chemical Communications
25. The role of the VQIVYK peptide in tau protein phosphorylation
    Mar Pérez, Ismael Santa‐María, Elena Tortosa, Raquel Cuadros, Mercedes del Valle, Félix Hernández, Francisco Javier Moreno, Jesús Ávila · 2007 · Journal of Neurochemistry
26. Serotonin‐induced activation of the network for locomotion in adult spinal rats
    D. Feraboli‐Lohnherr, Jean‐Yves Barthe, D. Orsal · 1999 · Journal of Neuroscience Research
27. Alzheimer s disease and heparan sulfate proteoglycan
    Ken-ichiro Fukuchi · 1998 · Frontiers in bioscience
28. Cortical Neuropathology in Aging and Dementing Disorders
    Patrick R. Hof, Constantin Bouras, John H. Morrison · 1999 · Cerebral cortex
29. Tau proteinopathies and the prion concept
    2020 · Progress in Molecular Biology and Translational Science
30. The Role of Extracellular Matrix Components in the Spreading of Pathological Protein Aggregates
    Edoardo Moretto, Skye Stuart, Sunaina Surana, Jose Norberto S. Vargas, Giampietro Schiavo · 2022 · Frontiers in Cellular Neuroscience
31. NMR Meets Tau: Insights into Its Function and Pathology
    Guy M. Lippens, Isabelle Landrieu, Caroline Smet‐Nocca, Isabelle Huvent, Neha S. Gandhi, Benoı̂t Gigant, Clément Despres, Haoling Qi, Juan M. Lopez · 2016 · Biomolecules
32. Conformational heterogeneity of tau: Implication on intrinsic disorder, acid stability and fibrillation in Alzheimer's disease
    Benita Jebarupa, Monita Muralidharan, Arun Arumugaperumal, Amit Kumar Mandal, Gopa Mitra · 2018 · Biophysical Chemistry
33. Molecular mechanisms underlying actions of certain long noncoding RNAs in Alzheimer’s disease
    Shamseddin Ahmadi, Mohammad Zobeiri, Steven Bradburn · 2020 · Metabolic Brain Disease
34. Uncovering specificity of endogenous TAU aggregation in a human iPSC-neuron TAU seeding model
    Manos, Justine D., Preiss, Christina N., Venkat, Nandini, Tamm, Joseph, Reinhardt, Peter, Kwon, Taekyung, Wu, Jessica, Winter, Allison D., Jahn, Thomas R., Yanamandra, Kiran et al. · 2022 · iScience
35. Tau Protein and Frontotemporal Dementias
    Michel Goedert, Maria Grazia Spillantini, Benjamin Falcon, Wenjuan Zhang, Kathy L. Newell, Masato Hasegawa, Sjors H. W. Scheres, Bernardino Francesco Ghetti · 2021 · Advances in experimental medicine and biology
36. Remodeling of the conformational ensemble of the repeat domain of tau by an aggregation enhancer
    Elias Akoury, Marco D. Mukrasch, Jacek Biernat, Katharina Tepper, Valéry Ozenne, Eckhard Mandelkow�, Martin J Blackledge, Markus Zweckstetter · 2016 · Protein Science
37. Zn2+ Interrupts R4‐R3 Association Leading to Accelerated Aggregation of Tau Protein
    A. C. Jiji, Arshad Abdul Vahid, Dhanya S. Reselammal, P. S. Shabana, C. K. Mehjubin, Vinesh Vijayan · 2017 · Chemistry - A European Journal
38. Amyloidogenic cross-seeding of Tau protein: Transient emergence of structural variants of fibrils
    Bartosz Niżyński, Hanna Nieznańska, Robert Dec, Solomiia Boyko, Wojciech Dzwolak, Krzysztof Nieznański · 2018 · PLoS ONE
39. Conformational Evolution of Molecular Signatures during Amyloidogenic Protein Aggregation
    George Devitt, William Rice, Anna Crisford, Iris S. Nandhakumar, Amritpal K. Mudher, Sumeet Mahajan · 2019 · ACS Chemical Neuroscience
40. Pharmacological Modulators of Tau Aggregation and Spreading
    Antonio Dominguez‐Meijide, Eftychia Vasili, Tiago F. Outeiro · 2020 · Brain Sciences
41. Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity
    Luciana Medina, Florencia González‐Lizárraga, Antonio Dominguez‐Meijide, Diego Ploper, Valeria Parrales, Sabrina Sequeira, Maria‐Sol Cima‐Omori, Markus Zweckstetter, Elaine Aparecida Del Bel, Patrick Pierre Michel et al. · 2021 · Frontiers in Aging Neuroscience
42. A novel D-amino acid peptide with therapeutic potential (ISAD1) inhibits aggregation of neurotoxic disease-relevant mutant Tau and prevents Tau toxicity in vitro
    Isabelle Aillaud, Senthilvelrajan Kaniyappan, RamReddy Chandupatla, Lisa Marie Ramirez, Sewar Alkhashrom, Jutta Eichler, Anselm H. C. Horn, Markus Zweckstetter, Eckhard Mandelkow�, Heinrich Sticht et al. · 2022 · Alzheimer s Research & Therapy
43. Tau Aggregation Propensity Engrained in Its Solution State
    Neil A. Eschmann, Thanh D. Do, Nichole E. LaPointe, Joan‐Emma Shea, Stuart C. Feinstein, Michael T. Bowers, Songi Han · 2015 · The Journal of Physical Chemistry B
44. Hyperphosphorylation induces structural modification of tau‐protein
    Vladimir Nikolaevich Uversky, Stefan Winter, Oxana V. Galzitskaya, Leonhard Kittler, G. Löber · 1998 · FEBS Letters
45. Chemical Synthesis Reveals Pathogenic Role of N-Glycosylation in Microtubule-Associated Protein Tau
    Wyatt C. Powell, Ruiheng Jing, Morgane Herlory, Patrick Holland, Darya Poliyenko, Christopher C. Ebmeier, Michael H. B. Stowell, Maciej A. A. Walczak · 2025 · Journal of the American Chemical Society
46. Tau Filaments and the Development of Positron Emission Tomography Tracers
    Michel Goedert, Yoshiki Yamaguchi, Sushil K. Mishra, Makoto Higuchi, Naruhiko Sahara · 2018 · Frontiers in Neurology
47. Is there a link between inorganic polyphosphate (polyP), mitochondria, and neurodegeneration?
    Emily A. Borden, Matthew Furey, Nicholas J. Gattone, Vedangi D. Hambardikar, Xiao Hua Liang, Ernest R. Scoma, Antonella Abou Samra, LaKeshia R. D-Gary, Dayshaun J. Dennis, Daniel Fricker et al. · 2020 · Pharmacological Research
48. Rapid oligomer formation of human muscle acylphosphatase induced by heparan sulfate
    Neda Motamedi‐Shad, Tommaso Garfagnini, Amanda Penco, Annalisa Relini, Federico Fogolari, Alessandra Corazza, Gennaro Esposito, Francesco Bemporad, Fabrizio Chiti · 2012 · Nature Structural & Molecular Biology
49. Molecular interactions of amyloid nanofibrils with biological aggregation modifiers: implications for cytotoxicity mechanisms and biomaterial design
    Durga Dharmadana, Nicholas P. Reynolds, Charlotte E. Conn, Céline Valéry · 2017 · Interface Focus
50. The antidepressant drug; trazodone inhibits Tau amyloidogenesis: Prospects for prophylaxis and treatment of AD
    Vali Akbari, Sirous Ghobadi, Soheila Mohammadi, Reza Khodarahmi‬ · 2019 · Archives of Biochemistry and Biophysics
51. Interaction of Alzheimer's disease amyloid β peptide fragment 25–35 with tau protein, and with a tau peptide containing the microtubule binding domain
    Mar Pérez, Raquel Cuadros, María José Benítez, Juan S. Jiménez · 2004 · Journal of Alzheimer s Disease
52. Animal Models of Neurological Disease
    Amol Shah, Tomás Garzón-Muvdi, Rohit K. Mahajan, Vincent J. Duenas, Alfredo Quiñones-Hinojosa · 2010 · Advances in experimental medicine and biology
53. What Else Can ‘Heparin’ Do?
    Ulf Lindahl · 1999 · Pathophysiology of Haemostasis and Thrombosis
54. Fluorescence-Based Monitoring of Early-Stage Aggregation of Amyloid-β, Amylin Peptide, Tau, and α-Synuclein Proteins
    Yuanjie Li, Saurabh Awasthi, Louise C. Bryan, Rachel S. Ehrlich, Nicolò Tonali, Sandor Balog, Jerry Yang, Norbert Sewald, Michael Mayer · 2024 · ACS Chemical Neuroscience
55. Cryo-EM structures of τ filaments from human brain
    Michel Goedert · 2021 · Essays in Biochemistry
56. Alzheimer’s Disease and Tau Self-Assembly: In the Search of the Missing Link
    Andrea González, Sandeep Kumar Singh, Macarena Churruca, Ricardo Benjamin Maccioni · 2022 · International Journal of Molecular Sciences
57. Cellular Interaction and Cytotoxicity of the Iowa Mutation of Apolipoprotein A-I (ApoA-IIowa) Amyloid Mediated by Sulfate Moieties of Heparan Sulfate
    Kaori Kuwabara, Kazuchika Nishitsuji, Kenji Uchimura, Shang‐Cheng Hung, Makoto Mizuguchi, Hiroyuki Nakajima, Shiho Mikawa, Norihiro Kobayashi, Hiroyuki Saito, Naomi Sakashita · 2015 · Journal of Biological Chemistry
58. Effects of different anti‐tau antibodies on tau fibrillogenesis: RTA‐1 and RTA‐2 counteract tau aggregation
    Taizo Taniguchi, Miho Sumida, Shuko Hiraoka, Koji Tomoo, Tomoko Kakehi, Katsuhiko Minoura, Shigeru Sugiyama, Koji Inaka, Toshimasa Ishida, Naoaki Saito et al. · 2005 · FEBS Letters
59. Alzheimer’s disease seeded tau forms paired helical filaments yet lacks seeding potential
    Pu Duan, Aurelio James Dregni, Hong Wei Xu, Lakshmi N. Changolkar, Virginia M.‐Y. Lee, Edward B. Lee, Mei Hong · 2024 · Journal of Biological Chemistry
60. Simplified method to obtain enhanced expression of tau protein fromE. coliand one-step purification by direct boiling
    V. Guru KrishnaKumar, Sharad Kumar Gupta · 2017 · Preparative Biochemistry & Biotechnology
61. An automated microliter-scale high-throughput screening system (MSHTS) for real-time monitoring of protein aggregation using quantum-dot nanoprobes
    Rina Sasaki, Reina Tainaka, Yukio Ando, Yurika Hashi, Hadya Virupaksha Deepak, Yoshiko Suga, Yuta Murai, Masaki Anetai, Kenji Monde, Kiminori Ohta et al. · 2019 · Scientific Reports
62. Non-Rodent Genetic Animal Models for Studying Tauopathy: Review of Drosophila, Zebrafish, and C. elegans Models
    Hoi-Khoanh Giong, Manivannan Subramanian, Kweon Yu, Jeong-Soo Lee · 2021 · International Journal of Molecular Sciences
63. Conformations of Microtubule-Associated Protein Tau Mapped by Fluorescence Resonance Energy Transfer
    Sadasivam Jeganathan�, Subashchandrabose Chinnathambi, Eva‐Maria Mandelkow, Eckhard Mandelkow� · 2012 · Methods in molecular biology
64. The misfolding mechanism of the key fragment R3 of tau protein: a combined molecular dynamics simulation and Markov state model study
    Hongli Liu, Haiyang Zhong, Zerong Xu, Qianqian Zhang, Syed Jawad Ali Shah, Huanxiang Liu, Xiaojun Yao · 2020 · Physical Chemistry Chemical Physics
65. Inhibition of CK2 mitigates Alzheimer’s tau pathology by preventing NR2B synaptic mislocalization
    Courtney A. Marshall, Jennifer D. McBride, Lakshmi N. Changolkar, Dawn M. Riddle, John Q. Trojanowski, Virginia M.‐Y. Lee · 2022 · Acta Neuropathologica Communications
66. Initiation and modulation of Tau protein phase separation by the drug suramin
    Prabhu Rajaiah Prince, Janine Hochmair, Hevila Brognaro, Susanna Gevorgyan, Maximilian Franck, Robin Schubert, Kristina Lorenzen, Selin Yazici, Eckhard Mandelkow�, Susanne Wegmann et al. · 2023 · Scientific Reports
67. Linkage‐dependent contribution of repeat peptides to self‐aggregation of three‐ or four‐repeat microtubule‐binding domains in tau protein
    Kayoko Okuyama, Chisato Nishiura, Fumie Mizushima, Katsuhiko Minoura, Miho Sumida, Taizo Taniguchi, Koji Tomoo, Toshimasa Ishida · 2008 · FEBS Journal
68. Phosphorylation modulates the alpha-helical structure and polymerization of a peptide from the third tau microtubule-binding repeat
    Jesús Mendieta, Miguel Angel Fuertes, Rani Kunjishapatham, Ismael Santa‐María, Francisco Javier Moreno, Carlos Alonso‐Moreno, Federico Gago, Víctor Muñoz, Jesús Ávila, Félix Hernández · 2004 · Biochimica et Biophysica Acta (BBA) - General Subjects
69. Tau-positive neurons in corticobasal degeneration and Alzheimer's disease - distinction by thiazin red and silver impregnations
    Toshiki Uchihara, Ayako Nakamura, Mineo Yamazaki, Osamu Mori · 2000 · Acta Neuropathologica
70. High-Resolution Magic Angle Spinning NMR of the Neuronal Tau Protein Integrated in Alzheimer's-Like Paired Helical Fragments
    Alain Sillen, Jean‐Michel Wieruszeski, Arnaud Leroy, Amena Ben Younes‐Chennoufi, Isabelle Landrieu, Guy M. Lippens · 2005 · Journal of the American Chemical Society
71. Tau mRNA isoforms following sciatic nerve axotomy with and without regeneration
    Christopher B. Chambers, Nancy A. Muma · 1997 · Molecular Brain Research
72. Molecular Origins of the Compatibility between Glycosaminoglycans and Aβ40 Amyloid Fibrils
    Katie L. Stewart, Eleri Hughes, Edwin Alexander Yates, David A. Middleton, Sheena E. Radford · 2017 · Journal of Molecular Biology
73. Terminal Capping of an Amyloidogenic Tau Fragment Modulates Its Fibrillation Propensity
    Shruti Arya, Pritam Ganguly, Andrea Arsiccio, Sarah L. Claud, Benjamin Trapp, Grace E. Schonfeld, Xikun Liu, Kristi Lazar Cantrell, Joan‐Emma Shea, Michael T. Bowers · 2020 · The Journal of Physical Chemistry B
74. Inhibition of tau amyloid formation and disruption of its preformed fibrils by Naphthoquinone–Dopamine hybrid
    Ashim Paul, Guru KrishnaKumar Viswanathan, Adi Huber, Elad Arad, Hamutal Engel, Raz Jelinek, Ehud Gazit, Daniel Segal · 2021 · FEBS Journal
75. Abnormal distribution of neurofilament L in neurons with Alzheimer's disease
    Yu Nakamura, Ryota Hasimoto, Yujiro Kashiwagi, Yasuyuki Miyamae, Kazuhiro Shinosaki, Takashi Nishikawa, Hideyuki Hattori, Takashi Kudo, Masatoshi Takeda · 1997 · Neuroscience Letters
76. Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers
    Ismael Santa‐María, Félix Hernández, Mark A. Smith, George L. Perry, Jesús Ávila, Francisco Javier Moreno · 2005 · Molecular and Cellular Biochemistry
77. Cerebrospinal fluid levels of A beta 42 and tau: potential markers of Alzheimer's disease.
    Douglas R Galasko · 1998 · PubMed
78. Sugar glues for broken neurons
    Vimal P. Swarup, Caitlin P. Mencio, Vladimir Hlady, Balagurunathan Kuberan · 2013 · BioMolecular Concepts
79. PIP2 Phospholipid‐Induced Aggregation of Tau Filaments Probed by Tip‐Enhanced Raman Spectroscopy
    David Talaga, Willy Smeralda, Laurie Lescos, Julien Hunel, Nad'a Lepejova-Caudy, Christophe Cullin, Sébastien Bonhommeau, Sophie Lecomte · 2018 · Angewandte Chemie International Edition
80. FTD-tau S320F mutation stabilizes local structure and allosterically promotes amyloid motif-dependent aggregation
    Dailu Chen, Sofia Bali, Ruhar Singh, Aleksandra Wosztyl, Vishruth Mullapudi, Jaime Vaquer‐Alicea, Parvathy Jayan, Shamiram Melhem, Harro Seelaar, John Cornelis Van Swieten et al. · 2023 · Nature Communications
81. Amyloid fibril structures of tau: Conformational plasticity of the second microtubule-binding repeat
    Nadia El Mammeri, Pu Duan, Aurelio James Dregni, Mei Hong · 2023 · Science Advances
82. Phosphorylation sensitizes microtubule-associated protein τ to Al3+-induced aggregation
    Wěi Li, K. Y. Kenneth, Wei Sun, Hemant K. Paudel · 1998 · Neurochemical Research
83. Effect of human neuronal tau on denaturation and reactivation of rabbit muscle D-glyceraldehyde-3-phosphate dehydrogenase
    Yong-Hui CHEN, Rong-Qiao He, Ying LIU, Yang Liu, Zhigang Xue · 2000 · Biochemical Journal
84. A unifying hypothesis of Alzheimer's disease. II. Pathophysiological processes
    Kurt Heininger · 1999 · Human Psychopharmacology Clinical and Experimental
85. Argyrophilic Grain Disease
    Markus Tolnay, Andreas Urs Monsch, A. Probst · 2001 · Advances in experimental medicine and biology
86. Paired helical filaments in corticobasal degeneration: the fine fibrillary structure with NanoVan
    Elzbieta Tracz, Dennis W. Dickson, James F. Hainfeld, Hanna Ksiȩżak-Reding · 1997 · Brain Research
87. Assay of Brain Endogenous Formaldehyde With 2, 4-Dinitrophenylhydrazine Through UV-HPLC*
    Tao SU, Wei Yan, Rongqiao He · 2012 · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS
88. Heparan sulfate S-domains and extracellular sulfatases (Sulfs): their possible roles in protein aggregation diseases
    Kazuchika Nishitsuji · 2018 · Glycoconjugate Journal
89. Dityrosine cross-linking and its potential roles in Alzheimer’s disease
    Mahmoud Bukar Maina, Youssra K. Al‐Hilaly, Louise C. Serpell · 2023 · Frontiers in Neuroscience
90. Disease-associated patterns of acetylation stabilize tau fibril formation
    Li, Li, Nguyen, Binh A., Mullapudi, Vishruth, Li, Yang, Saelices, Lorena, Joachimiak, Lukasz A. · 2023 · Structure
91. Absence of a Role for Phosphorylation in the Tau Pathology of Alzheimer’s Disease
    Robert Y. K. Lai, Charles R. Harrington, Claude M. Wischik · 2016 · Biomolecules
92. Frequency shift feedback imaging in liquid for biological molecules
    Hiroshi Sekiguchi, Takaharu Okajima, Hideo Arakawa, Sumihiro Maeda, Akihiko Takashima, Atsushi Ikai · 2003 · Applied Surface Science
93. Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs
    Félix Hernández, Mar Pérez, José J. Lucas, Jesús Ávila · 2002 · Brain Research
94. Multiple Roles of Heparin in the Aggregation of p25α
    Søren B. Nielsen, Pernille Yde, Lise Giehm, Sabrina Sundbye, Gunna Christiansen, Joachim Mathiesen, Mogens H. Jensen, Poul Henning Jensen, Daniel E. Otzen · 2012 · Journal of Molecular Biology
95. A thiol-based intramolecular redox switch in four-repeat tau controls fibril assembly and disassembly
    Hilary A. Weismiller, Tyler J. Holub, Brad J. Krzesinski, Martin Margittai · 2021 · Journal of Biological Chemistry
96. Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological Applications
    Hedieh Shahpasand‐Kroner, Ibrar Ahmed Siddique, Ravinder Malik, Gabriel R. Linares, Magdalena I. Ivanova, Justin K. Ichida, Tatjana Weil, Jan Münch, Elsa Sánchez‐García, Frank‐Gerrit Klärner et al. · 2022 · Pharmacological Reviews
97. Concentration-dependent effects of proteasomal inhibition on tau processing in a cellular model of tauopathy.
    Tadanori Hamano, Tania F. Gendron, Li‐wen Ko, Shu-Hui C. Yen · 2009 · Europe PMC (PubMed Central)
98. Arrayed CRISPR reveals genetic regulators of tau aggregation, autophagy and mitochondria in Alzheimer’s disease model
    Lishu Duan, Mufeng Hu, Joseph A. Tamm, Yelena Y. Grinberg, Fang Shen, Yating Chai, Hualin Simon Xi, Lauren Gibilisco, Brinda Ravikumar, Vivek Gautam et al. · 2021 · Scientific Reports
99. Appearance of tau-2 immunoreactivity in glial cells in human brain with cerebral infarction
    Toshiki Uchihara, Kuniaki Tsuchiya, Ayako Nakamura, Kenji Ikeda · 2000 · Neuroscience Letters
100. Interactions between Microtubule-Associated Protein Tau (MAPT) and Small Molecules
     Jennifer N. Rauch, Steven H. Olson, Jason E. Gestwicki · 2016 · Cold Spring Harbor Perspectives in Medicine